Warby Parker Inc. Class A Common Stock (WRBY)
StalwartFairStock Score: 28/100 — RISKY
Key Financials
| Current Price | $28.73 |
| Market Cap | $2.7B |
| P/E Ratio | 2,873 |
| ROE | 0.37% |
| Dividend Yield | —% |
| Sector | Healthcare |
Strengths
- Generates $33 million in annual free cash flow (1.2% yield on market cap)
Concerns
- Trades significantly above Graham Number ($1) with negative 2631% margin of safety—limited downside protection
- Currently unprofitable—sustained losses could lead to dilutive capital raises or balance sheet deterioration
- Weak Piotroski F-Score of 3/9 suggests deteriorating financial quality across multiple dimensions
AI Analysis
Warby Parker Inc. Class A Common Stock is a small-cap healthcare company valued at $2.7 billion. Revenue stands at $872 million, though the company is currently unprofitable. From a quality standpoint, Warby shows weak Piotroski F-Score of 3/9 signaling deteriorating fundamentals and healthy Altman Z-Score of 3.9. On valuation, the stock is commanding a steep 2246.0x multiple, with trades far above its Graham Number ($1) with no margin of safety. Growth dynamics show revenue growing at 11.2% and profit growth of 13.4%. Our composite FairStock Score of 28/100 reflects below-average fundamentals overall. Without profitability, this remains speculative—suitable only for those with high risk tolerance and a long time horizon.
Bull Case
Improving fundamentals and sector tailwinds could drive meaningful earnings growth, compressing the effective multiple for patient investors. With $33 million in annual free cash flow (1.2% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.
Bear Case
At 2246x earnings, any growth disappointment triggers rapid multiple compression—a 20% earnings miss plus multiple contraction to 20x implies 40%+ downside. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer